Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/11747483/hvidovre-hospital-why-we-have-implemented-supar <p>In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. <br></p><p><a href="http://biologictube.dk/photo/11747483/hvidovre-hospital-why-we-have-implemented-supar"><img src="http://biologictube.dk/10820443/11747483/56f6f45ae412228e1969e5c435f7b8a8/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/11747483 Thu, 09 Jul 2015 14:24:23 GMT Hvidovre Hospital - why we have implemented suPAR in clinical routine In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. Welcome to the BioLogicTube 01:35 <p>In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department. <br></p><p><a href="http://biologictube.dk/photo/11747483/hvidovre-hospital-why-we-have-implemented-supar"><img src="http://biologictube.dk/10820443/11747483/56f6f45ae412228e1969e5c435f7b8a8/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> copenhagen university crp disease elderly hvidovre hospital immune activation inflammation prognosis prognostic risk risk recognition routine biomarker severe severity severity and prognosis. supar is a biomarker of disease presence triage virogates http://biologictube.dk/photo/10033014/overview-of-the-5th-international-supar <p>The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of suPAR as a risk triage marker in the Acute Medical Department. Data from the routine use as well research data complemented into a conclusion that suPAR helps changing the clinical decision. Should the patient be admitted? Sent home? Rushed to the ICU? This and more was discussed by almost 100 clinicians and researchers over the 2-day seminar.</p><p><a href="http://biologictube.dk/photo/10033014/overview-of-the-5th-international-supar"><img src="http://biologictube.dk/9826383/10033014/acaf7b023048d8ce68e8cd246c8ce21f/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/10033014 Fri, 25 Jul 2014 14:38:49 GMT Overview of the 5'th International suPAR symposium The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of suPAR as a risk triage marker in the Acute Medical Department. Data from the routine use as well research data complemented into a conclusion that suPAR helps changing the clinical decision. Should the patient be admitted? Sent home? Rushed to the ICU? This and more was discussed by almost 100 clinicians and researchers over the 2-day seminar. The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of... Welcome to the BioLogicTube 04:55 <p>The 5th suPAR symposium was hosted by Prof. Markus Schultz and held at the Amsterdam Medical Center in May 2014. New and recently published data were presented and gave insights into the clinical use of suPAR. This years focus was on the use of suPAR as a risk triage marker in the Acute Medical Department. Data from the routine use as well research data complemented into a conclusion that suPAR helps changing the clinical decision. Should the patient be admitted? Sent home? Rushed to the ICU? This and more was discussed by almost 100 clinicians and researchers over the 2-day seminar.</p><p><a href="http://biologictube.dk/photo/10033014/overview-of-the-5th-international-supar"><img src="http://biologictube.dk/9826383/10033014/acaf7b023048d8ce68e8cd246c8ce21f/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> alexander koch artigas beat muller crp denmark diagnosis diagnostic elisa finland france frank tacke gremany helle fisker jakob knudsen jesper eugen-olsen jurki thenunen kenya margarethe persson ove andersen pct poland pro-adm procalcitonine prognosis prognostic quick triage soluble urokinase plasminogen acivator receptor suparnostic sweden terese djärv tine k andersen torben mogensen http://biologictube.dk/photo/9922017/dr-august-wrotek-talks-on-supar-as <p>The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wrotek's presentation was one of 25 lectures given over the 2-day 5'th International suPAR&nbsp;symposium. The programme and info on the conference can be found here: <a href="http://www.ViroGates.com">www.ViroGates.com</a><br><br></p><p><a href="http://biologictube.dk/photo/9922017/dr-august-wrotek-talks-on-supar-as"><img src="http://biologictube.dk/9826383/9922017/5f4832e6602fb1c2dba96fe3257a99ee/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/9922017 Fri, 13 Jun 2014 11:43:12 GMT Dr. August Wrotek talks on suPAR as marker of severity of pneumonia in children The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wrotek's presentation was one of 25 lectures given over the 2-day 5'th International suPARsymposium. The programme and info on the conference can be found here: www.ViroGates.com The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus... Welcome to the BioLogicTube 08:45 <p>The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wrotek's presentation was one of 25 lectures given over the 2-day 5'th International suPAR&nbsp;symposium. The programme and info on the conference can be found here: <a href="http://www.ViroGates.com">www.ViroGates.com</a><br><br></p><p><a href="http://biologictube.dk/photo/9922017/dr-august-wrotek-talks-on-supar-as"><img src="http://biologictube.dk/9826383/9922017/5f4832e6602fb1c2dba96fe3257a99ee/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> activator acut care acute care triage children cut-of cut-off diagnosis diagnostic disease disease severity emergency triage plasminogen pneumonia prediction prognosis prognostic receptor risk risk stratification soluble supar triage urokinase http://biologictube.dk/photo/9922086/dr-rafal-wlazel-talks-on-supar-and <p>The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wlazel's presentation was one of 25 lectures gicen over the 2-day Internationl suPAR&nbsp;symposium</p><p><a href="http://biologictube.dk/photo/9922086/dr-rafal-wlazel-talks-on-supar-and"><img src="http://biologictube.dk/9826383/9922086/516962cb20d5459ef9d59ccacaa692cc/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/9922086 Fri, 13 Jun 2014 11:41:26 GMT Dr. Rafal Wlazel talks on suPAR and prediction of AMI in pPCI patients The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wlazel's presentation was one of 25 lectures gicen over the 2-day Internationl suPARsymposium The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus... Welcome to the BioLogicTube 09:09 <p>The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May 2014. The symposium was entitled suPAR and its clinical use and focused on suPAR as a triage marker in the emergency room. The symposium was hosted by professor Marcus Schultz from the Amsterdam Medical Center. Dr. Wlazel's presentation was one of 25 lectures gicen over the 2-day Internationl suPAR&nbsp;symposium</p><p><a href="http://biologictube.dk/photo/9922086/dr-rafal-wlazel-talks-on-supar-and"><img src="http://biologictube.dk/9826383/9922086/516962cb20d5459ef9d59ccacaa692cc/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> acute care biomarker biomarker triage cardiac eugen-olsen frank tacke helle fisker hvidovre hosptal inflammation jakob knudsen markus schultz medical triage nstemi pci poland prediction prognostic risk risk prediction risk stratification soluble urokinase plasminogen activator receptor stemi supar triage virogates http://biologictube.dk/photo/8180961/4th-international-supar-symposium-1 <p>Almost 100 researchers met to present new data and discuss the potential of the suPAR biomarker in triage in the emergency room and ICU setting. <br><p>The 4th International suPAR symposium was held in late February in 2013 in Aachen, Germany.<br></p> <p>This years suPAR symposium was entitled ” New Horizons for suPAR: Risk Stratification, Organ Dysfunction and Relevance for Specific Diseases”.</p> <p>Almost 100 researchers from all over the world met to discuss the potential use of the prognostic biomarker suPAR.<br> <br>The symposium was hosted by Professor Frank Tacke and Dr Alexander Koch from Aachen University Hospital<br> <br>The talks started with insights into suPAR biology and pathology with ”state of the art lecture” given by professor Jochen Reiser from Chicago on the causative effect of suPAR in kidney diseases. This was followed by an overview on suPAR in Kidney diseases, liver diseases and finally in pulmonary diseases.</p> <p>The overviews were followed by presentations on exciting new data on suPAR in liver cirrhosis – where does suPAR come from, how is it regulated, what is its prognostic relevance?</p> <p>Following this, new data on the role of suPAR in low-grade inflammation, Atherosclerosis and Life Style Diseases were presented and discussed and approximately half of the attendees had their blood drawn for suPAR measurement</p><p> <br>Hereafter chief Physician Jyrki Tenhunen gave an overview on the large amount of data published within the last year with emphesis on sepsis</p><p> Finally, on day 1, new data on suPAR and its prognostic value in Inflammatory and Infectious Diseases and Sepsis were presented and the Usefulness of suPAR in Risk Stratification of Patients with sepsis Admitted to the Emergency Department were discussed</p> <p>As the day turned into night, the researchers met to socialize and exchange ideas at the suPARTY.</p><p>On day 2, after some black coffee, the researchers presented data and discussed how biomarkers may aid in clinical decision making – in particular in sepsis, Cardiology, Kidney failure, liver failure and finally in cancer.The last session gave insight into the use of suPAR as a marker of triaging in the emergency department. And Katia Donadello closed the symposium with a presentation on the potential use of suPAR in the intensive care unit.</p><br><br></p><p><a href="http://biologictube.dk/photo/8180961/4th-international-supar-symposium-1"><img src="http://biologictube.dk/7718126/8180961/0244b212cd863af3ed7448f7248fea61/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/8180961 Wed, 20 Nov 2013 16:13:27 GMT 4th International suPAR symposium Overview Almost 100 researchers met to present new data and discuss the potential of the suPAR biomarker in triage in the emergency room and ICU setting. The 4th International suPAR symposium was held in late February in 2013 in Aachen, Germany. This years suPAR symposium was entitled ” New Horizons for suPAR: Risk Stratification, Organ Dysfunction and Relevance for Specific Diseases”. Almost 100 researchers from all over the world met to discuss the potential use of the prognostic biomarker suPAR. The symposium was hosted by Professor Frank Tacke and Dr Alexander Koch from Aachen University Hospital The talks started with insights into suPAR biology and pathology with ”state of the art lecture” given by professor Jochen Reiser from Chicago on the causative effect of suPAR in kidney diseases. This was followed by an overview on suPAR in Kidney diseases, liver diseases and finally in pulmonary diseases. The overviews were followed by presentations on exciting new data on suPAR in liver cirrhosis – where does suPAR come from, how is it regulated, what is its prognostic relevance? Following this, new data on the role of suPAR in low-grade inflammation, Atherosclerosis and Life Style Diseases were presented and discussed and approximately half of the attendees had their blood drawn for suPAR measurement Hereafter chief Physician Jyrki Tenhunen gave an overview on the large amount of data published within the last year with emphesis on sepsis Finally, on day 1, new data on suPAR and its prognostic value in Inflammatory and Infectious Diseases and Sepsis were presented and the Usefulness of suPAR in Risk Stratification of Patients with sepsis Admitted to the Emergency Department were discussed As the day turned into night, the researchers met to socialize and exchange ideas at the suPARTY.On day 2, after some black coffee, the researchers presented data and discussed how biomarkers may aid in clinical decision making – in particular in sepsis, Cardiology, Kidney failure, liver failure and finally in cancer.The last session gave insight into the use of suPAR as a marker of triaging in the emergency department. And Katia Donadello closed the symposium with a presentation on the potential use of suPAR in the intensive care unit. Almost 100 researchers met to present new data and discuss the potential of the suPAR biomarker in triage in the emergency room and ICU setting. The 4th International suPAR symposium was held in late February in 2013 in Aachen, Germany. This... Welcome to the BioLogicTube 06:59 <p>Almost 100 researchers met to present new data and discuss the potential of the suPAR biomarker in triage in the emergency room and ICU setting. <br><p>The 4th International suPAR symposium was held in late February in 2013 in Aachen, Germany.<br></p> <p>This years suPAR symposium was entitled ” New Horizons for suPAR: Risk Stratification, Organ Dysfunction and Relevance for Specific Diseases”.</p> <p>Almost 100 researchers from all over the world met to discuss the potential use of the prognostic biomarker suPAR.<br> <br>The symposium was hosted by Professor Frank Tacke and Dr Alexander Koch from Aachen University Hospital<br> <br>The talks started with insights into suPAR biology and pathology with ”state of the art lecture” given by professor Jochen Reiser from Chicago on the causative effect of suPAR in kidney diseases. This was followed by an overview on suPAR in Kidney diseases, liver diseases and finally in pulmonary diseases.</p> <p>The overviews were followed by presentations on exciting new data on suPAR in liver cirrhosis – where does suPAR come from, how is it regulated, what is its prognostic relevance?</p> <p>Following this, new data on the role of suPAR in low-grade inflammation, Atherosclerosis and Life Style Diseases were presented and discussed and approximately half of the attendees had their blood drawn for suPAR measurement</p><p> <br>Hereafter chief Physician Jyrki Tenhunen gave an overview on the large amount of data published within the last year with emphesis on sepsis</p><p> Finally, on day 1, new data on suPAR and its prognostic value in Inflammatory and Infectious Diseases and Sepsis were presented and the Usefulness of suPAR in Risk Stratification of Patients with sepsis Admitted to the Emergency Department were discussed</p> <p>As the day turned into night, the researchers met to socialize and exchange ideas at the suPARTY.</p><p>On day 2, after some black coffee, the researchers presented data and discussed how biomarkers may aid in clinical decision making – in particular in sepsis, Cardiology, Kidney failure, liver failure and finally in cancer.The last session gave insight into the use of suPAR as a marker of triaging in the emergency department. And Katia Donadello closed the symposium with a presentation on the potential use of suPAR in the intensive care unit.</p><br><br></p><p><a href="http://biologictube.dk/photo/8180961/4th-international-supar-symposium-1"><img src="http://biologictube.dk/7718126/8180961/0244b212cd863af3ed7448f7248fea61/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> aachen alexander koch amsterdam 2014 apache biomarker blood eugen olsen frank tacke plasma prognosis prognostic risk status marker soluble urokinase plasminogen activator recptor virogates http://biologictube.dk/photo/7958383/from-1st-to-4th-supar-symposium-what <p>suPAR researcher Jesper Eugen-Olsen gives an overview of the suPAR data generated during the symposiums. <br></p><p><a href="http://biologictube.dk/photo/7958383/from-1st-to-4th-supar-symposium-what"><img src="http://biologictube.dk/7718128/7958383/b9a8f2e88b7a797bd5609f9b2049a18b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7958383 Tue, 21 May 2013 15:46:02 GMT From 1st to 4th suPAR symposium - What have we learned? suPAR researcher Jesper Eugen-Olsen gives an overview of the suPAR data generated during the symposiums. suPAR researcher Jesper Eugen-Olsen gives an overview of the suPAR data generated during the symposiums. Welcome to the BioLogicTube 15:51 <p>suPAR researcher Jesper Eugen-Olsen gives an overview of the suPAR data generated during the symposiums. <br></p><p><a href="http://biologictube.dk/photo/7958383/from-1st-to-4th-supar-symposium-what"><img src="http://biologictube.dk/7718128/7958383/b9a8f2e88b7a797bd5609f9b2049a18b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Aachen Hvidovre Hospital Prognosis prognostic soluble urkinase Plasminogen Activator Receptor http://biologictube.dk/photo/6564713/teaser-for-the-4th <p>The 4th International suPAR symposium will be hosted by Drs. Frank Tacke and Alexander Koch from Aachen University Hospital in Germany. The symposium will be held at the super C building in Aachen on the 25-26th of February 2013.</p><p><a href="http://biologictube.dk/photo/6564713/teaser-for-the-4th"><img src="http://biologictube.dk/4959050/6564713/77ddfad0ebda3e82b8dab2b48e1e9a9b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/6564713 Wed, 18 Jul 2012 21:20:17 GMT Teaser for the 4th International suPAR symposium, 2013 The 4th International suPAR symposium will be hosted by Drs. Frank Tacke and Alexander Koch from Aachen University Hospital in Germany. The symposium will be held at the super C building in Aachen on the 25-26th of February 2013. The 4th International suPAR symposium will be hosted by Drs. Frank Tacke and Alexander Koch from Aachen University Hospital in Germany. The symposium will be held at the super C building in Aachen on the 25-26th of February 2013. Welcome to the BioLogicTube 01:34 <p>The 4th International suPAR symposium will be hosted by Drs. Frank Tacke and Alexander Koch from Aachen University Hospital in Germany. The symposium will be held at the super C building in Aachen on the 25-26th of February 2013.</p><p><a href="http://biologictube.dk/photo/6564713/teaser-for-the-4th"><img src="http://biologictube.dk/4959050/6564713/77ddfad0ebda3e82b8dab2b48e1e9a9b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> CVD Eugen-Olsen Fisker Helle Jakob Knudsen T2D Tacke ViroGates biomarker disease emergency failure lifestyle management organ prognosis prognostic receptor risk room soluble suPARnostic triage triaging urokinase